EW vs OMCL · P/E 47, rev $1.39B vs P/E 90, rev $1.11B
Edwards Lifesciences Corp (EW) versus Omnicell Inc (OMCL) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Omnicell Inc (OMCL) is a health information services company listed on NASDAQ.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported OMCL revenue for 2024-12-31 was $1.11B. Net income was $12.5M. Revenue was down 3.0% from 2023-12-31 to 2024-12-31. OMCL currently screens at market cap $1.80B and trailing P/E 89.9.
EW currently screens at market cap $49.91B and trailing P/E 46.9. OMCL currently screens at market cap $1.80B and trailing P/E 89.9.
Not investment advice. Open the EW and OMCL stock pages for the full models.
Not investment advice.